Al-Qahtani AA .2020 .Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): emergence, history, basic and clinical aspects. Saudi J Biol Sci, 27 : 2531-8.
. .. Health Advisory Platform by Ministry of National Health Services Regulations and Coordination, 08 : .
Malik YA .2020 .Properties of coronavirus and SARS-CoV-2. Malays J Pathol, 42 : 3-11.
Zaidi S,Rizwan F,Riaz Q,Siddiqui A,Khawaja S,Imam M .2021 .Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19. J Public Health, 43 : 3-8.
Zhou P,Yang XL,Wang XG,Hu B,Zhang L,Zhang W .2020 .A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579 : 270-3.
Liu B,Li M,Zhou Z,Guan X,Xiang Y. .2020 .Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS. J Autoimmun, 111 : 102452.
Wang Y,Wang Y,Chen Y,Qin Q. .2020 .Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol, 92 : 568-76.
Aziz KM,Othman A,Alqahtani W .2021 .Factors affecting SARS-CoV-2 (COVID-19) Pandemic, including Zoonotic, Human Transmission and Chain of Infection. Reducing Public health Risk by Serum Antibody Testing, Avoiding Screening in Unhygienic Places and False PCR Reporting. Iberoam J Med, 3 : 138-60.
Stringhini S,Wisniak A,Piumatti G,Azman AS,Lauer SA,Baysson H .2020 .Seroprevalence of anti-SARS-CoV2 IgG antibodies in Geneva, Switzerland (SEROCoVPOP): a population-based study. Lancet, 396 : 313-9.
Chughtai OR,Batool H,Khan MD,Chughtai AS .2020 .Frequency of COVID-19 IgG antibodies among special police squad Lahore, Pakistan. J Coll Physicians Surg Pak, 30 : 735-9.
Nisar MI,Ansari N,Khalid F,Amin M,Shahbaz H,Hotwani A .2021 .Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan. Int J Infect Dis, 106 : 176-82.
Megasari NL,Utsumi T,Yamani LN,Gunawan E,Furukawa K,Nishimura M .2021 .Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia. PLoS One, 16 : e0251234.
Afzal N,Tariq N,Shakeel D,Sultan S. .2021 .Trend of AntiSARS-COV-2 Seropositivity in Karachi. Nat J Health Sci, 5 : 104-8.
Pollán M,Pérez-Gómez B,Pastor-Barriuso R,Oteo J,Pérez-Olmeda M,Yotti R .2020 .SARS-CoV-2 seroprevalence in Spain-Authors' reply. Lancet, 396 : 1484-5.
Haq M,Rehman A,Ahmad J,Zafar U,Ahmed S,Khan MA .2021 .SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?. Infection, 49 : 983-8.
Tahir S,Tahir SA,Arif TB,Majid B,Majid Z,Malik F .2020 .Epidemiological and clinical features of SARSCoV-2: a retrospective study from East Karachi, Pakistan. Cureus, 12 : e8679.
Wu Z,McGoogan JM .2020 .Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 323 : 1239-42.
Oran DP,Topol EJ .2020 .Prevalence of asymptomatic SARSCoV-2 infection: a narrative review. Ann Intern Med, 173 : 362-7.
Burgess S,Ponsford MJ,Gill D.,BMJ D. .2020 .Are we underestimating seroprevalence of SARS-CoV-2. , 370 : m3364.